Last Updated:
Access Report
Name Designation Appointment Date Status
Pratima Rajendra Dhole

Appointed as Director since February 2010

 Director 12-Feb-2010 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Rajendra Sheshrao Dhole

Appointed as Director since February 2010

 Director 12-Feb-2010 Current

People Timeline

Explore the timeline of key personnel in Rholence Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address 103, New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur Maharashtra, 440024, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 440024
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Rholence Pharmaceuticals Private Limited?
You can contact Rholence Pharmaceuticals Private Limited through their registered address at 103, New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur Maharashtra, 440024, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Rholence Pharmaceuticals Private Limited?
The current directors of Rholence Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • PRATIMA RAJENDRA DHOLE
  • RAJENDRA SHESHRAO DHOLE
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available